News Briefs.
- Published in:
- American Journal of Health-System Pharmacy, 2012, v. 69, n. 4, p. 274
- Publication type:
- Article
Works matching IS 10792082 AND DT 2012 AND VI 69 AND IP 4
Results: 16
1
2
Pharmacy department not liable for use of contraindicated drug in surgical suite.
- Published in:
- American Journal of Health-System Pharmacy, 2012, v. 69, n. 4, p. 349, doi. 10.2146/ajhp110602
- By:
- Publication type:
- Article
3
Evaluation of a transplantation specialty pharmacy program.
- Published in:
- American Journal of Health-System Pharmacy, 2012, v. 69, n. 4, p. 340, doi. 10.2146/ajhp110350
- By:
- Publication type:
- Article
4
Strategies to preserve the use of statins in patients with previous muscular adverse effects.
- Published in:
- American Journal of Health-System Pharmacy, 2012, v. 69, n. 4, p. 291, doi. 10.2146/ajhp100700
- By:
- Publication type:
- Article
5
Development and implementation of a clinical pharmacist training and assessment program.
- Published in:
- American Journal of Health-System Pharmacy, 2012, v. 69, n. 4, p. 278, doi. 10.2146/ajhp110253
- By:
- Publication type:
- Article
6
Correction.
- Published in:
- 2012
- Publication type:
- Correction Notice
7
Monitoring adverse drug reactions across a nationwide health care system using information technology.
- Published in:
- American Journal of Health-System Pharmacy, 2012, v. 69, n. 4, p. 321, doi. 10.2146/ajhp110026
- By:
- Publication type:
- Article
8
Impact of atrial fibrillation and oral anticoagulation on hospital costs and length of stay.
- Published in:
- American Journal of Health-System Pharmacy, 2012, v. 69, n. 4, p. 329, doi. 10.2146/ajhp110203
- By:
- Publication type:
- Article
9
Managing peak performers.
- Published in:
- American Journal of Health-System Pharmacy, 2012, v. 69, n. 4, p. 282, doi. 10.2146/ajhp110375
- By:
- Publication type:
- Article
10
OF SPECIAL INTEREST.
- Published in:
- American Journal of Health-System Pharmacy, 2012, v. 69, n. 4, p. 269
- Publication type:
- Article
11
Comparison of rates of reported adverse events associated with i.v. iron products in the United States.
- Published in:
- American Journal of Health-System Pharmacy, 2012, v. 69, n. 4, p. 310, doi. 10.2146/ajhp110262
- By:
- Publication type:
- Article
12
Persistent elevation of peripheral blood myeloid cell counts associated with omalizumab therapy.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
13
Remote technician supervision up and running in Kansas.
- Published in:
- American Journal of Health-System Pharmacy, 2012, v. 69, n. 4, p. 273, doi. 10.2146/news120014
- By:
- Publication type:
- Article
14
Medication guides leave their REMS programs behind.
- Published in:
- American Journal of Health-System Pharmacy, 2012, v. 69, n. 4, p. 272, doi. 10.2146/news120013
- By:
- Publication type:
- Article
15
One IVIG mystery solved, another demands vigilance.
- Published in:
- American Journal of Health-System Pharmacy, 2012, v. 69, n. 4, p. 271, doi. 10.2146/news120012
- By:
- Publication type:
- Article
16
Using integrated learning modules to increase involvement in ASHP student society.
- Published in:
- 2012
- By:
- Publication type:
- Letter